Patents Assigned to University of Notre Dame du Lac
  • Patent number: 11296742
    Abstract: Aspects of the subject disclosure may include, for example, receiving, by a first radio module at a first location, a wireless MIMO signal, to obtain a first received RF signal. The wireless MIMO signal includes information originating at a remote MIMO transmitter and conveyed via a wireless channel. An envelope of the first received RF signal is detected by the first radio module without requiring a local oscillator, to obtain a first baseband signal. The first baseband signal may be filtered and/or amplified, after which it is compared to a reference value to obtain a first digital signal that is provided to a digital processor. The digital processor also obtains a second digital signal from a second radio module receiving the wireless MIMO signal at a second location and determines an estimate of the information originating at the remote MIMO transmitter according to the first and second digital signals. Other embodiments are disclosed.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: April 5, 2022
    Assignees: AT&T Intellectual Property I, L.P., University of Notre Dame du Lac
    Inventors: Ralf Bendlin, Jonathan David Chisum, Nicholas Joseph Estes, Bertrand Martyn Hochwald, Aditya Chopra
  • Patent number: 11293057
    Abstract: The invention provides an alternating current electrospray technology that can generate micron sized droplets in oil at very high throughput for emulsion or digital PCR (Polymerase Chain Reaction). This technology outperforms the throughput of the current gold standard in droplet generation using flow-focusing technology by at least a factor of 100. The design is simple and can generate a billion to a trillion monodispersed droplets in about one hour. This is much faster than flow-focusing which is limited to a few million droplets per hour. The droplet size and generation rate can also be easily adjusted by changing the voltage of the AC electric field. The range of produced droplet sizes is about 1-100 microns, wherein the droplets are monodispersed in size.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: April 5, 2022
    Assignee: University of Notre Dame du Lac
    Inventors: Hsueh-Chia Chang, David B. Go, Zdenek Slouka, Satyajyoti Senapati, Yongfan Men, Zehao Pan
  • Publication number: 20220071999
    Abstract: Described are compounds and compositions that inhibit or target Cyt-bd, and methods of making, using, and assaying same. Also disclosed are compositions, methods and kits including the compounds and compositions that inhibit or target Cyt-bd, and one or more Cyt-bc1:aa3 inhibitor, F1F0-ATP synthase inhibitor, NADH dehydrogenase (NDH-2) inhibitor, NADH dehydrogenase (NDH-2) activator or antibacterial agent.
    Type: Application
    Filed: December 19, 2019
    Publication date: March 10, 2022
    Applicants: UNIVERSITY OF NOTRE DAME DU LAC, MONTANA STATE UNIVERSITY, NANYANG TECHNOLOGICAL UNIVERSITY
    Inventors: Marvin J. MILLER, Garrett C. MORASKI, Kevin PETHE
  • Patent number: 11252965
    Abstract: The present invention provides a novel class of insecticides for control of disease vector insects, particularly mosquitoes. These insecticides prevent maturation or development of larvae into adult insects using interfering RNA (iRNA). The present invention further includes compositions comprising iRNA and methods of controlling, reducing, or treating an insect infestation with the iRNA or compositions described herein.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: February 22, 2022
    Assignees: Indiana University Research and Technology Corporation, University of Notre Dame Du Lac
    Inventors: Molly Duman Scheel, David W. Severson, Kathleen Eggleson, Na Wei
  • Patent number: 11239877
    Abstract: Aspects of the subject disclosure may include, for example, generating multiple digital reference pulses synchronously to a master oscillator, selectively switching the multiple digital reference pulses, and providing the switched pulses to multiple radio modules operating within a millimeter wave spectrum. For each radio module, counting cycles of an adjustable LO output signal occurring between consecutive pulses of the switched digital reference pulses, determining a difference between the count value and a reference value, and adjusting the adjustable LO according to the difference. A resulting corrected LO signal is synchronized to the master oscillator. Other embodiments are disclosed.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: February 1, 2022
    Assignees: AT&T INTELLECTUAL PROPERTY I, L.P., UNIVERSITY OF NOTRE DAME DU LAC
    Inventors: Aditya Chopra, Ralf Bendlin, Nicholas Joseph Estes, Kang Gao, Bertrand Martyn Hochwald, Jonathan David Chisum
  • Patent number: 11219608
    Abstract: The disclosure relates to use of a triple formulation comprising a histone deacetylase, a cyclodextrin and polyethylene glycol or propylene glycol, and in the treatment and management of chronic pain.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: January 11, 2022
    Assignees: Northwestern University, The University of Notre Dame Du Lac
    Inventors: A. Vania Apkarian, Kasturi Haldar, Suhail Alam, Maria Virginia Centeno
  • Publication number: 20220002497
    Abstract: A highly permeable sorbent platform based on polysulfone and polystyrene-b-poly(acrylic acid) composite membranes. The membranes possess a fully interconnected network of poly(acrylic acid)-lined pores, which enables the surface chemistry to be tailored through sequential attachment of polyethyleneimine moieties and metal-binding terpyridine ligands. The polyethyleneimine moieties increase the saturation capacity, while the addition of terpyridine enables high-affinity binding to a diversity of transition metal ions. This membrane platform removes such metal contaminants from solution. The metal capture performance of the functionalized membranes persists even in high concentrations of competitive ions. Also, fluorescence quenching of the terpyridine moiety upon metal ion complexation offers an in-situ probe to monitor the extent of sorbent saturation.
    Type: Application
    Filed: October 30, 2019
    Publication date: January 6, 2022
    Applicants: University of Notre Dame du Lac, Purdue Research Foundation
    Inventors: Yizhou ZHANG, William A. PHILLIP, Matthew J. WEBBER, Bryan W. BOUDOURIS
  • Patent number: 11198911
    Abstract: Products, systems, and methods for classifying human colorectal cancer into a consensus molecular subtype (CMS) and for assessing risk of recurrence based on CMS scores and based on risk scores derived from abbreviated gene expression profiles, for determining suitable treatment protocols for human colorectal cancer patients based on the determined CMS classification and based on the determined risk of recurrence, and for administering the suitable treatment protocols.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: December 14, 2021
    Assignee: UNIVERSITY OF NOTRE DAME DU LAC
    Inventor: Steven Buechler
  • Patent number: 11181668
    Abstract: A film comprising a first plurality of voids is provided, wherein respective ones of the first plurality of voids have a regular n-gon geometry, and the first plurality of voids are arranged on a regular n-gon lattice having a first size. The film may comprise a second plurality of voids arranged on a regular n-gon lattice having a second size different from the first size. An optical element and manufacturing method are also provided.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: November 23, 2021
    Assignee: University of Notre Dame du Lac
    Inventors: Jonathan Chisum, Nicolas Garcia
  • Patent number: 11181727
    Abstract: One aspect of the present disclosure relates to systems and methods that can be used for super-sensitivity multiphoton frequency-domain fluorescence lifetime imaging microscopy (MPM-FD-FLIM). One or more laser light sources can deliver excitation light with an intensity modulated by a periodic function to a sample, which includes a fluorophore concentration. A receiver can receive a fluorescence signal emitted from the fluorophore concentration over a time period. A computing device can transform the fluorescence signal to the frequency domain and measure a fluorescence lifetime associated with the sample in the frequency domain based on a DC component and at least one higher harmonic component generated by non-linear optical mixing of the modulated excitation light. Using the DC component and the at least one higher harmonic component can increase the sensitivity of an image created by the MPM-FD-FLIM system.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: November 23, 2021
    Assignee: UNIVERSITY OF NOTRE DAME DU LAC
    Inventors: Scott Howard, Genevieve Vigil, Yide Zhang
  • Patent number: 11168062
    Abstract: Clostridium difficile infection (CDI) is a public health threat that results in 14,000 annual deaths in the United States. Challenges involve the production of CDI spores that can remain dormant for years and the production of toxins that damage the gut. Current therapies for CDI include vancomycin and metronidazole, but neither inhibits spore or toxin production. Thus, recurrence of infection occurs in 25% of patients and there are no antibiotics that are effective for multiple recurrences. We describe oxadiazoles with activity against C. difficile, including the highly virulent NAP1/027 strain with increased production of toxins A and B, as well as the additional binary toxin. Oxadiazole 2 is poorly absorbed, thus advantageously achieving high concentrations in the gut. The compound targets peptidoglycan synthesis and inhibits vegetative cells, spores, and toxin production.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: November 9, 2021
    Assignee: University of Notre Dame du Lac
    Inventors: Mayland Chang, Shahriar Mobashery, Derong Ding
  • Publication number: 20210340117
    Abstract: Clostridium difficile infection (CDI) is a public health threat that results in 14,000 annual deaths in the United States. Challenges involve the production of CDI spores that can remain dormant for years and the production of toxins that damage the gut. Current therapies for CDI include vancomycin and metronidazole, but neither inhibits spore or toxin production. Thus, recurrence of infection occurs in 25% of patients and there are no antibiotics that are effective for multiple recurrences. We describe oxadiazoles with activity against C. difficile, including the highly virulent NAP1/027 strain with increased production of toxins A and B, as well as the additional binary toxin. Oxadiazole 2 is poorly absorbed, thus advantageously achieving high concentrations in the gut. The compound targets peptidoglycan synthesis and inhibits vegetative cells, spores, and toxin production.
    Type: Application
    Filed: July 15, 2021
    Publication date: November 4, 2021
    Applicant: University of Notre Dame du Lac
    Inventors: Mayland CHANG, Shahriar MOBASHERY, Derong DING
  • Publication number: 20210340116
    Abstract: Clostridium difficile infection (CDI) is a public health threat that results in 14,000 annual deaths in the United States. Challenges involve the production of CDI spores that can remain dormant for years and the production of toxins that damage the gut. Current therapies for CDI include vancomycin and metronidazole, but neither inhibits spore or toxin production. Thus, recurrence of infection occurs in 25% of patients and there are no antibiotics that are effective for multiple recurrences. We describe oxadiazoles with activity against C. difficile, including the highly virulent NAP1/027 strain with increased production of toxins A and B, as well as the additional binary toxin. Oxadiazole 2 is poorly absorbed, thus advantageously achieving high concentrations in the gut. The compound targets peptidoglycan synthesis and inhibits vegetative cells, spores, and toxin production.
    Type: Application
    Filed: July 15, 2021
    Publication date: November 4, 2021
    Applicant: University of Notre Dame du Lac
    Inventors: Mayland CHANG, Shahriar MOBASHERY, Derong DING
  • Patent number: 11162880
    Abstract: A particle separation multi-membrane matrix device and method are provided. The particles isolated may comprise nano-scale particles, such extracellular membrane vesicles, having a size of about 50 to about 150 nm. The vesicles are released by many different cell types, and may be efficiently isolated at high yield and purity according to the present methods from various body fluids (e.g., blood, saliva, breast milk, serum, plasma, ascites fluid, etc.). Such isolated exosome preparations may include biomarkers, such as disease biomarkers (diagnostic markers) for various disease (early stage and late stage cancers, neurological disorders (Parkinson disease, Alzheimer disease), diabetes, pancreatic diseases, renal failure, infectious diseases (HIV, tuberculosis, malaria, hepatitis)). The present methods and devices may be used to detect and monitor animals (human, livestock, companion animal) for infectious diseases, such as tuberculosis and other diseases.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: November 2, 2021
    Assignee: University of Notre Dame du Lac
    Inventors: Jeffrey S. Schorey, Yong Cheng
  • Patent number: 11162935
    Abstract: Systems and methods for controlling molecular translocation in solid-state nanopores by edge field leakage. The system dramatically reduces (by orders of magnitude) and controls the fast electrophoretic velocity of molecules to realize sensitive and selective solid-state nanopore sensors for polynucleotides and sequencing platforms.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: November 2, 2021
    Assignee: University of Notre Dame du Lac
    Inventors: Ceming Wang, Satyajyoti Senapati, Hsueh-Chia Chang
  • Patent number: 11155542
    Abstract: The present invention relates to the general field of treatment of infectious diseases of mammals (humans and animals) caused by bacteria, in particular to the treatment of diseases like tuberculosis (TB), Buruli ulcer and leprosy caused by mycobacteria. The invention aims at the generation of a new series of benzothiazinone compounds having the potential to overcome the above mentioned problems. In a preferred embodiment the invention is concerned with compounds of the general formula (I) wherein R1 represents NO2, R2 represents CF3, at least one of the substituents R3 and R4 is OH, SR14, NHR15, CN, N3, a saturated or unsaturated, optionally halogenated, linear or branched aliphatic radical having 1-4 carbon atoms, linear or branched C1-C4 alkoxy, C1-C4 acyl, and the other of R3 and R4 may in addition be hydrogen, R6 represents a 2-methyl-1,4-dioxa-8-azaspiro[4.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: October 26, 2021
    Assignees: University of Notre Dame Du Lac
    Inventors: Florian Kloss, Sebastian Schieferdecker, Axel Brakhage, Julia Dreisbach, Marvin J. Miller, Ute Mollmann, Kamil Philip Wojtas
  • Patent number: 11131631
    Abstract: A microscopy method and system includes obtaining a plurality of raw fluorescence images, respective ones of the plurality of raw fluorescence images obtained by exciting a sample using a light source at a respective irradiance value in a weak saturation region of the sample, and capturing the respective raw fluorescence image; applying a plurality of weights to the plurality of raw fluorescence images in a one-to-one correspondence so as to generate a plurality of weighted fluorescence images, wherein a respective weight is based on the respective irradiance value at which the corresponding raw fluorescence image was obtained; and linearly combining the plurality of weighted fluorescence images, thereby generating the output image having a resolution greater than a diffraction limit. Respective raw fluorescence images correspond to irradiance values different from one another.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: September 28, 2021
    Assignee: UNIVERSITY OF NOTRE DAME DU LAC
    Inventors: Scott S. Howard, Yide Zhang, Cody J. Smith
  • Patent number: 11121896
    Abstract: Aspects of the subject disclosure may include, for example, receiving a radio frequency (RF) signal having a carrier wave component that operates at a carrier frequency within a millimeter wave spectrum. The RF signal also includes an information component based on a phase shift keying (PSK) modulation of the carrier wave component. A local oscillator (LO) signal is obtained, which includes an LO frequency that approximates the carrier frequency. The received RF signal and the LO signal are combined without using signal multiplication to obtain a first combined output signal. The first combined output signal being detected via a non-linear energy detector to obtain a first detected signal. The first output signal includes information of the information component. Other embodiments are disclosed.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: September 14, 2021
    Assignees: AT&T Intellectual Property I, L.P., University of Notre Dame du Lac
    Inventors: Ralf Bendlin, Aditya Chopra, Bertrand Martyn Hochwald, Nicholas Joseph Estes, Jonathan David Chisum, Kang Gao
  • Patent number: 11116848
    Abstract: A method of crosslinking a hetero-bifunctional photo crosslinking compound to an immunoglobulin having at least one heterocyclic photo reactive group and at least one non-photo reactive group where the non-photo reactive group is coupled to an effector molecule and the photo reactive group is coupled to the nucleotide binding site of an immunoglobulin. Alternatively, the photo crosslinker contains an orthogonal reactive group such as a thiol, which can be coupled to an effector molecule or functionalized ligand.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: September 14, 2021
    Assignee: University of Notre Dame du Lac
    Inventors: Zihni Basar Bilgicer, Nathan J. Alves
  • Publication number: 20210277023
    Abstract: Provided are antibiotic conjugate compounds of formula (I) and pharmaceutical compositions thereof. Also provided are methods of treating treat bacterial infection, including infections caused by Gram-negative bacteria, by administering compounds of formula (I).
    Type: Application
    Filed: August 9, 2018
    Publication date: September 9, 2021
    Applicant: UNIVERSITY OF NOTRE DAME DU LAC
    Inventors: Marvin J. MILLER, Rui LIU, Patricia MILLER, Sergei VAKULENKO, Nichole K. STEWART, William BOGGESS